Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Oil in COVID-19 ICU Patients
NCT04836052Phase 3Unknown
- Sponsor
- Hamad Medical Corporation
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3 fatty acid in coronavirus disease 2019 (COVID-19), sponsored by Hamad Medical Corporation. Status: unknown.
02
Drugs
omega-3 fatty acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04836052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04836052.